Music Licensing, Inc. (OTC: SONG) Receives Royalty Payment for Ownership Stake in Listerine Antiseptic
Music Licensing, Inc. (OTC: SONG), a diversified holding company, has announced the receipt of a royalty payment from its ownership stake in Listerine® Antiseptic (Mouthwash). The company's interest in the globally recognized oral hygiene brand continues to perform well in the market, contributing to a steady revenue stream. Jake P. Noch, CEO of Music Licensing, Inc., expressed pride in the payment, highlighting its significance in creating sustainable, long-term value for shareholders.
The company's strategy involves diversified asset holdings, including high-profile consumer goods and investments in both the entertainment and consumer goods sectors. This approach reinforces Music Licensing, Inc.'s position as a leader in intellectual property and royalty-based assets, demonstrating its commitment to maximizing shareholder value through strategic portfolio management.
Music Licensing, Inc. (OTC: SONG), una società di holding diversificata, ha annunciato di aver ricevuto un pagamento di royalty dalla sua partecipazione in Listerine® Antiseptic (Collutorio). L'interesse dell'azienda nel marchio di igiene orale riconosciuto a livello globale continua a performare bene nel mercato, contribuendo a un flusso di entrate costante. Jake P. Noch, CEO di Music Licensing, Inc., ha espresso orgoglio per il pagamento, sottolineando la sua importanza nella creazione di valore sostenibile e a lungo termine per gli azionisti.
La strategia dell'azienda prevede holding di asset diversificati, tra cui beni di consumo di alto profilo e investimenti nei settori dell'intrattenimento e dei beni di consumo. Questo approccio rafforza la posizione di Music Licensing, Inc. come leader in proprietà intellettuale e asset basati su royalty, dimostrando il suo impegno a massimizzare il valore per gli azionisti attraverso una gestione strategica del portafoglio.
Music Licensing, Inc. (OTC: SONG), una empresa de holdings diversificada, ha anunciado la recepción de un pago de regalías por su participación en Listerine® Antiseptic (Enjuague bucal). El interés de la compañía en la reconocida marca de higiene oral a nivel mundial sigue rindiendo bien en el mercado, contribuyendo a un flujo de ingresos constante. Jake P. Noch, CEO de Music Licensing, Inc., expresó su orgullo por el pago, destacando su importancia para crear un valor sostenible y a largo plazo para los accionistas.
La estrategia de la compañía incluye tenencias de activos diversificados, que abarcan bienes de consumo de alto perfil e inversiones en los sectores del entretenimiento y bienes de consumo. Este enfoque refuerza la posición de Music Licensing, Inc. como líder en propiedad intelectual y activos basados en regalías, demostrando su compromiso de maximizar el valor para los accionistas a través de una gestión estratégica de la cartera.
Music Licensing, Inc. (OTC: SONG), 다각화된 홀딩스 회사가 로열티 지급을 Listerine® Antiseptic (구강 세척제)의 소유 지분에서 수령했다고 발표했습니다. 이 회사의 글로벌 인지도를 자랑하는 구강 위생 브랜드에 대한 관심은 시장에서 잘 수행되고 있으며, 안정적인 수익 흐름에 기여하고 있습니다. 제이크 P. 노흐 Music Licensing, Inc.의 CEO는 이 지급에 대해 자부심을 표명하며 주주에게 지속 가능하고 장기적인 가치를 창출하는 데 중요한 의미가 있다고 강조했습니다.
회사의 전략은 다양화된 자산 보유를 포함하며, 고급 소비재와 엔터테인먼트 및 소비재 부문에 대한 투자를 포함합니다. 이러한 접근은 지적 재산권 및 로열티 기반 자산 분야에서 Music Licensing, Inc.의 리더십을 강화하며, 전략적 포트폴리오 관리를 통해 주주 가치를 극대화하려는 노력을 보여줍니다.
Music Licensing, Inc. (OTC: SONG), une société de holding diversifiée, a annoncé avoir reçu un paiement de redevances de sa participation dans Listerine® Antiseptic (Rince-bouche). L'intérêt de l'entreprise dans cette marque d'hygiène buccale reconnue mondialement continue d'avoir de bonnes performances sur le marché, contribuant à un flux de revenus stable. Jake P. Noch, PDG de Music Licensing, Inc., a exprimé sa fierté face à ce paiement, soulignant son importance dans la création de valeur durable à long terme pour les actionnaires.
La stratégie de l'entreprise inclut des avoirs diversifiés, comprenant des biens de consommation de haut profil et des investissements dans les secteurs du divertissement et des biens de consommation. Cette approche renforce la position de Music Licensing, Inc. en tant que leader dans le domaine des droits de propriété intellectuelle et des actifs basés sur des redevances, démontrant son engagement à maximiser la valeur pour les actionnaires par une gestion stratégique de portefeuille.
Music Licensing, Inc. (OTC: SONG), ein diversifiziertes Holding-Unternehmen, hat den Erhalt einer Royalties-Zahlung aus seiner Beteiligung an Listerine® Antiseptic (Mundspülung) bekannt gegeben. Das Interesse des Unternehmens an der weltweit anerkannten Mundhygienemarke erzielt weiterhin gute Ergebnisse auf dem Markt und trägt zu einem stabilen Einnahmenstrom bei. Jake P. Noch, CEO von Music Licensing, Inc., äußerte Stolz über die Zahlung und hob deren Bedeutung für die Schaffung von nachhaltigem, langfristigem Wert für die Aktionäre hervor.
Die Strategie des Unternehmens umfasst diversifizierte Vermögenswerte, darunter hochwertige Verbrauchsgüter und Investitionen in den Bereichen Unterhaltung und Verbrauchsgüter. Dieser Ansatz stärkt die Position von Music Licensing, Inc. als führendes Unternehmen im Bereich geistiges Eigentum und royalty-basierte Vermögenswerte und demonstriert das Engagement, den Wert für die Aktionäre durch strategisches Portfoliomanagement zu maximieren.
- Receipt of royalty payment from ownership stake in Listerine® Antiseptic
- Steady revenue stream from diversified asset holdings
- Strong market performance of the Listerine® brand
- None.
Naples, FL, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Music Licensing, Inc. (OTC: SONG), a diversified holding company, is pleased to announce the receipt of a royalty payment derived from its ownership stake in Listerine® Antiseptic (Mouthwash), a globally recognized brand in oral hygiene.
As part of its strategic portfolio, Music Licensing, Inc. holds a valuable interest in the Listerine® brand, which continues to perform exceptionally well in the marketplace. The latest royalty payment reflects the company's ongoing commitment to maximizing shareholder value through diversified asset holdings, including high-profile consumer goods.
“We are proud of the steady revenue stream generated from our stake in Listerine® Antiseptic,” said Jake P. Noch, CEO of Music Licensing, Inc. “This payment not only highlights the strength and reliability of our diverse portfolio but also underscores our ability to create sustainable, long-term value for our shareholders.”
Music Licensing, Inc. continues to pursue strategic investments in both the entertainment and consumer goods sectors, further reinforcing its position as a leader in intellectual property and royalty-based assets.
About Music Licensing, Inc. (OTC: SONG) (ProMusicRights.com)
Music Licensing, Inc. (OTC: SONG), also known as Pro Music Rights, is a diversified holding company and the fifth public performance rights organization (PRO) formed in the United States. Its licensees include notable companies such as TikTok, iHeart Media, Triller, Napster, 7Digital, Vevo, and many others. Pro Music Rights holds an estimated market share of
Additionally, Music Licensing, Inc. (OTC: SONG) owns royalty stakes in Listerine "Mouthwash" Antiseptic and musical works by artists such as The Weeknd, Justin Bieber, Kanye West, Elton John, Mike Posner, blackbear, Lil Nas X, Lil Yachty, DaBaby, Stunna 4 Vegas, Miley Cyrus, Lil Wayne, XXXTentacion, Jeremih, Ty Dolla $ign, Eric Bellinger, Ne-Yo, MoneyBagg Yo, Halsey, Desiigner, DaniLeigh, Rihanna, and numerous others.
Forward-Looking Statements:
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that, all forward-looking statements involve risks and uncertainties, including without limitation, the ability of Music Licensing, Inc. & Pro Music Rights, Inc. to accomplish its stated plan of business. Music Licensing, Inc. & Pro Music Rights, Inc. believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this press release will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by Pro Music Rights, Inc., Music Licensing, Inc., or any other person.
Non-Legal Advice Disclosure:
This press release does not constitute legal advice, and readers are advised to seek legal counsel for any legal matters or questions related to the content herein.
Non-Investment Advice Disclosure:
This communication is intended solely for informational purposes and does not in any way imply or constitute a recommendation or solicitation for the purchase or sale of any securities, commodities, bonds, options, derivatives, or any other investment products. Any decisions related to investments should be made after thorough research and consultation with a qualified financial advisor or professional. We assume no liability for any actions taken or not taken based on the information provided in this communication
Contact: investors@ProMusicRights.com
SOURCE: Music Licensing, Inc
FAQ
What royalty payment did Music Licensing, Inc. (OTC: SONG) receive in September 2024?
How does the Listerine® Antiseptic royalty payment benefit Music Licensing, Inc. (OTC: SONG)?
What is Music Licensing, Inc.'s (OTC: SONG) strategy for investments?
